| Year |
Citation |
Score |
| 2020 |
Cai MY, Dunn CE, Chen W, Kochupurakkal BS, Nguyen H, Moreau LA, Shapiro GI, Parmar K, Kozono D, D'Andrea AD. Cooperation of the ATM and Fanconi Anemia/BRCA Pathways in Double-Strand Break End Resection. Cell Reports. 30: 2402-2415.e5. PMID 32075772 DOI: 10.1016/J.Celrep.2020.01.052 |
0.317 |
|
| 2020 |
Kamran SC, Coroller T, Milani N, Agrawal V, Baldini EH, Chen AB, Johnson BE, Kozono D, Franco I, Chopra N, Zeleznik R, Aerts HJWL, Mak R. The impact of quantitative CT-based tumor volumetric features on the outcomes of patients with limited stage small cell lung cancer. Radiation Oncology (London, England). 15: 14. PMID 31937336 DOI: 10.1186/S13014-020-1460-4 |
0.326 |
|
| 2020 |
Ross HJ, Hu C, Higgins KA, Jabbour SK, Kozono DE, Owonikoko TK, Movsas B, Solberg T, Xiao C, Williams TM, Welsh JW, Simko J, Wang XF, Mohindra NA, Hsu C, et al. NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. Journal of Clinical Oncology. 38: TPS9082-TPS9082. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps9082 |
0.339 |
|
| 2020 |
Sands J, Mandrekar SJ, Oxnard GR, Kozono DE, Hillman SL, Dahlberg SE, Sun Z, Chaft JE, Govindan R, Gerber DE, Gray JE, Malik SM, Mooney MM, Janne PA, Vokes EE, et al. ALCHEMIST: Adjuvant targeted therapy or immunotherapy for high-risk resected NSCLC. Journal of Clinical Oncology. 38: TPS9077-TPS9077. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps9077 |
0.307 |
|
| 2020 |
Ross HJ, Kozono DE, Urbanic JJ, Williams TM, Dufrane C, Bara I, Gandhi M, Schulze K, Brockman JM, Wang XF, Gao J, Vokes EE, Stinchcombe T. AFT-16: Phase II trial of atezolizumab before and after definitive chemoradiation (CRT) for unresectable stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 38: 9045-9045. DOI: 10.1200/Jco.2020.38.15_Suppl.9045 |
0.31 |
|
| 2019 |
Mitra D, Chen YH, Li R, Hermann G, Atkins K, Kozono D, Baldini EH, Aizer A, Chukwueke U, Mak RH. EGFR mutant locally advanced non-small cell lung cancer is at increased risk of brain metastasis. Clinical and Translational Radiation Oncology. 18: 32-38. PMID 31341973 DOI: 10.1016/J.Ctro.2019.06.008 |
0.306 |
|
| 2019 |
Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, Kozono DE, Baldini EH, Chen AB, Nguyen PL, D'Amico AV, Nohria A, Hoffmann U, Aerts HJWL, Mak RH. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer. Journal of the American College of Cardiology. 73: 2976-2987. PMID 31196455 DOI: 10.1016/J.Jacc.2019.03.500 |
0.301 |
|
| 2018 |
Deraska PV, O'Leary C, Reavis HD, Labe S, Dinh TK, Lazaro JB, Sweeney C, D'Andrea AD, Kozono D. NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repair. Cell Death Discovery. 4: 10. PMID 29531807 DOI: 10.1038/S41420-017-0008-3 |
0.324 |
|
| 2018 |
Mitra D, Agarwal V, Chen Y, Baldini EH, Barbie DA, Chen AB, Glass B, Herman G, Kozono DE, Schoenfeld JD, Mak RH. The prognostic significance of PDL1 expression in locally advanced non-small-cell lung cancer (LA-NSCLC) treated with definitive intent. Journal of Clinical Oncology. 36: 150-150. DOI: 10.1200/Jco.2018.36.5_Suppl.150 |
0.319 |
|
| 2018 |
Deraska P, Reavis H, Labe S, D'Andrea A, Kozono D. Abstract 4287: Whole-genome CRISPR/Cas9 screen of the CHK1 inhibitor prexasertib implicates FAM122A loss as a potential resistance mechanism Cancer Research. 78: 4287-4287. DOI: 10.1158/1538-7445.Am2018-4287 |
0.316 |
|
| 2018 |
Chipidza FE, Franco I, Chen YH, Baldini EH, Chen AB, Kozono DE, Mak RH. Comorbidity is a Prognostic Factor in Early Stage Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1829 |
0.335 |
|
| 2018 |
Bitterman DS, Rawal B, Atkins KM, Chaunzwa TL, Diao K, Catalano PS, Baldini EH, Chen AB, Kozono DE, Mak RH. Predictors of Radiation Esophagitis in Locally Advanced Non-Small Cell Lung Cancer with Modern Radiation Therapy Planning International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.1821 |
0.322 |
|
| 2018 |
Atkins KM, Rawal B, Williams CL, Bitterman DS, Chaunzwa TL, Verma V, Kozono DE, Baldini EH, Chen AB, Nohria A, Aerts H, Mak RH. Cardiac Events after Radiation Therapy (RT) for Stage II-III Non-Small Cell Lung Cancer (NSCLC): Analysis of 748 Patients International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.06.236 |
0.331 |
|
| 2017 |
Franco I, Chen YH, Chipidza F, Agrawal V, Romano J, Baldini E, Chen A, Colson Y, Hou Y, Kozono D, Wee J, Mak R. Use of frailty to predict survival in elderly patients with early stage non-small-cell lung cancer treated with stereotactic body radiation therapy. Journal of Geriatric Oncology. PMID 28941581 DOI: 10.1016/J.Jgo.2017.09.002 |
0.341 |
|
| 2017 |
Kozono DE, Salama JK, Stinchcombe T, Bogart J, Petty WJ, Guarino MJ, Bazhenova L, Larner JM, Weiss J, DiPetrillo TA, Feigenberg SJ, Xu T, Hu B, Nuthalapati S, Rosenwinkel L, et al. Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P): Based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 35: 8546-8546. DOI: 10.1200/Jco.2017.35.15_Suppl.8546 |
0.333 |
|
| 2017 |
Deraska PV, Reavis HD, Labe S, D'Andrea AD, Kozono D. Abstract 4189: Homologous recombination pathway-based biomarkers for treatment of non-small cell lung cancer with PARP inhibitors Cancer Research. 77: 4189-4189. DOI: 10.1158/1538-7445.Am2017-4189 |
0.357 |
|
| 2016 |
Agrawal V, Coroller TP, Hou Y, Lee SW, Romano JL, Baldini EH, Chen AB, Jackman DM, Kozono D, Swanson SJ, Wee JO, Aerts HJ, Mak RH. Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC. Lung Cancer (Amsterdam, Netherlands). 102: 1-8. PMID 27987576 DOI: 10.1016/J.Lungcan.2016.10.002 |
0.313 |
|
| 2016 |
Hou Y, Hermann G, Lewis JH, Aerts HJ, Baldini EH, Chen AB, Colson YL, Hacker FL, Killoran JH, Kozono DE, Wagar M, Wee JO, Mak RH. Clinical Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With or Without a Prior Lung Resection. American Journal of Clinical Oncology. PMID 27819875 DOI: 10.1097/Coc.0000000000000344 |
0.32 |
|
| 2016 |
Hou Y, Lee S, Agrawal V, Romano J, Baldini EH, Chen AB, Kozono DE, Killoran JH, Wagar M, Hacker FL, Aerts HJ, Lewis JH, Mak RH. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer. Journal of Medical Imaging and Radiation Oncology. PMID 27709803 DOI: 10.1111/1754-9485.12537 |
0.33 |
|
| 2016 |
Mak RH, Hermann G, Aerts H, Chen AB, Baldini EH, Kozono DE, Chen YH, Catalano PJ, Janne P. Outcomes by EGFR, KRAS and ALK Genotype After Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: S156. PMID 27675664 DOI: 10.1016/J.Ijrobp.2016.06.378 |
0.317 |
|
| 2016 |
Yang D, O'Leary C, Deraska PV, D'Andrea AD, Haas-Kogan DA, Kozono DE. Exploiting Homologous Recombination Defects in N on-Small Cell Lung Cancer Through Combined PARP and Wee1 Inhibition. International Journal of Radiation Oncology, Biology, Physics. 96: E581-E582. PMID 27675075 DOI: 10.1016/J.Ijrobp.2016.06.2084 |
0.31 |
|
| 2016 |
Franco I, Romano J, Chipidza F, Baldini EH, Chen AB, Chen YH, Colson Y, Hou Y, Kozono DE, Wee J, Mak RH. Modified Frailty Index as a Predictor of Overall and Other Cause-Specific Survival in Early-Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: E449-E450. PMID 27674720 DOI: 10.1016/J.Ijrobp.2016.06.1760 |
0.341 |
|
| 2016 |
Li R, Hermann G, Baldini E, Chen A, Jackman D, Kozono D, Nguyen P, Nohria A, Powell G, Mak R. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 96: 41-7. PMID 27133748 DOI: 10.1016/J.Lungcan.2016.03.004 |
0.343 |
|
| 2016 |
Deraska PV, O’Leary C, Lazaro J, Sweeney CJ, D’Andrea AD, Kozono D. Abstract 1644: NF-κB inhibitor DMAPT blocks non-homologous end-joining repair of radiation-induced DSBs in NSCLC Cancer Research. 76: 1644-1644. DOI: 10.1158/1538-7445.Am2016-1644 |
0.329 |
|
| 2015 |
Kushwaha D, O'Leary C, Cron KR, Deraska P, Zhu K, D'Andrea AD, Kozono D. USP9X inhibition promotes radiation-induced apoptosis in non-small cell lung cancer cells expressing mid-to-high MCL1. Cancer Biology & Therapy. 16: 392-401. PMID 25692226 DOI: 10.1080/15384047.2014.1002358 |
0.346 |
|
| 2015 |
Mak RH, Hermann G, Lewis JH, Aerts HJ, Baldini EH, Chen AB, Colson YL, Hacker FH, Kozono D, Wee JO, Chen YH, Catalano PJ, Wong KK, Sher DJ. Outcomes by tumor histology and KRAS mutation status after lung stereotactic body radiation therapy for early-stage non-small-cell lung cancer. Clinical Lung Cancer. 16: 24-32. PMID 25450872 DOI: 10.1016/J.Cllc.2014.09.005 |
0.324 |
|
| 2015 |
Chen C, Kozono D, Li J, Nitta M, Sampetrean O, Ng K, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, et al. Abstract PR02: Dynamic epigenetic regulation of glioblastoma tumorigenicity through a LSD1-MYC-OLIG2 axis Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-Pr02 |
0.306 |
|
| 2015 |
Li J, Kozono D, Nitta M, Sampetrean O, Gonda D, Kushwaha DS, Merzon D, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, et al. Abstract 979: Dynamic epigenetic regulation of glioblastoma tumorigenicity through LSD1 modulation of MYC expression Cancer Research. 75: 979-979. DOI: 10.1158/1538-7445.Am2015-979 |
0.312 |
|
| 2015 |
Kozono D, Li J, Sampetrean O, Gonda D, Kushwaha D, Merzon D, Nitta M, Ramakrishnan V, Zhu S, Zhu K, Matsui H, Harismendy O, Hua W, Mao Y, Kwon C, et al. EPIG-02DYNAMIC EPIGENETIC MODULATION OF GLIOBLASTOMA TUMORIGENICITY BY INHIBITION OF LYSINE-SPECIFIC DEMETHYLASE 1 (LSD1) Neuro-Oncology. 17: v86.2-v86. DOI: 10.1093/Neuonc/Nov214.02 |
0.305 |
|
| 2014 |
Herter-Sprie GS, Korideck H, Christensen CL, Herter JM, Rhee K, Berbeco RI, Bennett DG, Akbay EA, Kozono D, Mak RH, Mike Makrigiorgos G, Kimmelman AC, Wong KK. Image-guided radiotherapy platform using single nodule conditional lung cancer mouse models. Nature Communications. 5: 5870. PMID 25519892 DOI: 10.1038/Ncomms6870 |
0.303 |
|
| 2014 |
Gray PJ, Mak RH, Yeap BY, Cryer SK, Pinnell NE, Christianson LW, Sher DJ, Arvold ND, Baldini EH, Chen AB, Kozono DE, Swanson SJ, Jackman DM, Alexander BM. Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival Lung Cancer. 85: 239-244. PMID 24974152 DOI: 10.1016/J.Lungcan.2014.06.001 |
0.306 |
|
| 2014 |
Parikh RB, Cronin AM, Kozono DE, Oxnard GR, Mak RH, Jackman DM, Lo PC, Baldini EH, Johnson BE, Chen AB. Definitive primary therapy in patients presenting with oligometastatic non-small cell lung cancer. International Journal of Radiation Oncology, Biology, Physics. 89: 880-7. PMID 24867533 DOI: 10.1016/J.Ijrobp.2014.04.007 |
0.321 |
|
| 2014 |
Gazula A, Baldini EH, Chen A, Kozono D. Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer. Lung. 192: 151-158. PMID 24162870 DOI: 10.1007/S00408-013-9518-9 |
0.323 |
|
| 2013 |
Cron KR, Zhu K, Kushwaha DS, Hsieh G, Merzon D, Rameseder J, Chen CC, D'Andrea AD, Kozono D. Proteasome inhibitors block DNA repair and radiosensitize non-small cell lung cancer. Plos One. 8: e73710. PMID 24040035 DOI: 10.1371/Journal.Pone.0073710 |
0.359 |
|
| 2013 |
Li J, Zhu S, Kozono D, Futulan D, Gonda D, Kushwaha D, Kahle K, Elledge S, Chen CC. Abstract 4366: ShRNA-based cellular proliferation signaling analysis revealed DRD2 as a novel therapeutic target for glioblastoma. Cancer Research. 73: 4366-4366. DOI: 10.1158/1538-7445.Am2013-4366 |
0.314 |
|
| 2013 |
Cron KR, Zhu K, Kushwaha D, Hsieh G, Merzon D, Monahan J, Chen CC, D'Andrea A, Kozono D. Abstract 1583: Proteasome inhibition as a strategy for non-small cell lung carcinoma via inhibition of DNA double strand break repair. Cancer Research. 73: 1583-1583. DOI: 10.1158/1538-7445.Am2013-1583 |
0.354 |
|
| 2013 |
Mak RH, Hermann G, Lewis JH, Baldini EH, Chen AB, Colson YL, Hacker FH, Kozono D, Wee JO, Sher DJ. Outcomes After Lung Stereotactic Body Radiation Therapy in Patients With K-ras-Mutant Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.1337 |
0.33 |
|
| 2013 |
Kozono DE, Cron K, Kushwaha D, D'Andrea AD. Proteasome Inhibitors Block DNA Repair and Radiosensitize Non-Small Cell Lung Cancer International Journal of Radiation Oncology Biology Physics. 87. DOI: 10.1016/J.Ijrobp.2013.06.060 |
0.319 |
|
| 2012 |
Zhu K, Kushwaha D, Cron K, Hsieh G, Merzon D, Evans D, Ng K, Chen CC, D'Andrea AD, Kozono D. Abstract 1448: Whole genome RNAi screen identifies proteasome inhibition as a strategy for NSCLC radiosensitization Cancer Research. 72: 1448-1448. DOI: 10.1158/1538-7445.Am2012-1448 |
0.361 |
|
| 2010 |
Nitta M, Kozono D, Kennedy R, Stommel J, Ng K, Zinn PO, Kushwaha D, Kesari S, Inda MM, Wykosky J, Furnari F, Hoadley KA, Chin L, DePinho RA, Cavenee WK, et al. Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy. Plos One. 5: e10767. PMID 20532243 DOI: 10.1371/Journal.Pone.0010767 |
0.305 |
|
| 2010 |
Kozono D, Ng K, Hsieh G, Merzon D, Nitta M, Zinn PO, Kahle K, Elledge S, D'Andrea A, Chen CC. Abstract 1318: Proteasome and Fanconi Anemia/BRCA pathways as prognostic determinants of glioblastoma response to radiation and temozolomide: a proposed clinical trial Cancer Research. 70: 1318-1318. DOI: 10.1158/1538-7445.Am10-1318 |
0.337 |
|
| 2006 |
Palanivelu DV, Kozono DE, Engel A, Suda K, Lustig A, Agre P, Schirmer T. Co-axial association of recombinant eye lens aquaporin-0 observed in loosely packed 3D crystals. Journal of Molecular Biology. 355: 605-11. PMID 16309700 DOI: 10.1016/J.Jmb.2005.10.032 |
0.497 |
|
| 2005 |
Lee JK, Kozono D, Remis J, Kitagawa Y, Agre P, Stroud RM. Structural basis for conductance by the archaeal aquaporin AqpM at 1.68 A. Proceedings of the National Academy of Sciences of the United States of America. 102: 18932-7. PMID 16361443 DOI: 10.1073/Pnas.0509469102 |
0.539 |
|
| 2005 |
Liu K, Kozono D, Kato Y, Agre P, Hazama A, Yasui M. Conversion of aquaporin 6 from an anion channel to a water-selective channel by a single amino acid substitution. Proceedings of the National Academy of Sciences of the United States of America. 102: 2192-7. PMID 15671159 DOI: 10.1073/Pnas.0409232102 |
0.549 |
|
| 2004 |
King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nature Reviews. Molecular Cell Biology. 5: 687-98. PMID 15340377 DOI: 10.1038/Nrm1469 |
0.547 |
|
| 2004 |
Agre P, Kozono D. Aquaporin water channels: molecular mechanisms for human diseases. Febs Letters. 555: 72-8. PMID 14630322 DOI: 10.1016/S0014-5793(03)01083-4 |
0.558 |
|
| 2004 |
Palanivelu D, Agre P, Kozono D, Lustig A, Suda K, Schirmer T. Co-axial association of eye lens aquaporin AQP0 Acta Crystallographica Section a Foundations of Crystallography. 60: s130-s130. DOI: 10.1107/S0108767304097430 |
0.41 |
|
| 2003 |
Carbrey JM, Gorelick-Feldman DA, Kozono D, Praetorius J, Nielsen S, Agre P. Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver. Proceedings of the National Academy of Sciences of the United States of America. 100: 2945-50. PMID 12594337 DOI: 10.1073/Pnas.0437994100 |
0.71 |
|
| 2003 |
Kozono D, Ding X, Iwasaki I, Meng X, Kamagata Y, Agre P, Kitagawa Y. Functional expression and characterization of an archaeal aquaporin. AqpM from methanothermobacter marburgensis. The Journal of Biological Chemistry. 278: 10649-56. PMID 12519768 DOI: 10.1074/Jbc.M212418200 |
0.544 |
|
| 2002 |
Ikeda M, Beitz E, Kozono D, Guggino WB, Agre P, Yasui M. Characterization of aquaporin-6 as a nitrate channel in mammalian cells. Requirement of pore-lining residue threonine 63. The Journal of Biological Chemistry. 277: 39873-9. PMID 12177001 DOI: 10.1074/Jbc.M207008200 |
0.555 |
|
| 2002 |
Kozono D, Yasui M, King LS, Agre P. Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine. The Journal of Clinical Investigation. 109: 1395-9. PMID 12045251 DOI: 10.1172/JCI15851 |
0.483 |
|
| 2002 |
Hazama A, Kozono D, Guggino WB, Agre P, Yasui M. Ion permeation of AQP6 water channel protein. Single channel recordings after Hg2+ activation. The Journal of Biological Chemistry. 277: 29224-30. PMID 12034750 DOI: 10.1074/Jbc.M204258200 |
0.538 |
|
| 2002 |
Kozono D, Yasui M, King LS, Agre P. Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine Journal of Clinical Investigation. 109: 1395-1399. DOI: 10.1172/Jci0215851 |
0.553 |
|
| 2001 |
Saparov SM, Kozono D, Rothe U, Agre P, Pohl P. Water and ion permeation of aquaporin-1 in planar lipid bilayers. Major differences in structural determinants and stoichiometry. The Journal of Biological Chemistry. 276: 31515-20. PMID 11410596 DOI: 10.1074/Jbc.M104267200 |
0.55 |
|
| 2001 |
Agre PC, Borgnia MJ, Yasui M, Neely JD, Carbrey J, Kozono D, Beitz E, Hoffert J, Leitch V, King LS. Chapter 1 discovery of the aquaporins and their impact on basic and clinical physiology Current Topics in Membranes. 51: 1-38. DOI: 10.1016/S1063-5823(01)51003-0 |
0.699 |
|
| 1999 |
Borgnia MJ, Kozono D, Calamita G, Maloney PC, Agre P. Functional reconstitution and characterization of AqpZ, the E. coli water channel protein. Journal of Molecular Biology. 291: 1169-79. PMID 10518952 DOI: 10.1006/Jmbi.1999.3032 |
0.541 |
|
| Show low-probability matches. |